Zeitschriftenartikel zum Thema „Disease progression score“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "Disease progression score" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.
Shan, Guogen, Xinlin Lu, Zhigang Li, Jessica Z. K. Caldwell, Charles Bernick und Jeffrey Cummings. „ADSS: A Composite Score to Detect Disease Progression in Alzheimer’s Disease“. Journal of Alzheimer's Disease Reports 8, Nr. 1 (20.02.2024): 307–16. http://dx.doi.org/10.3233/adr-230043.
Der volle Inhalt der QuelleRoussanov, Bisser V., Jeremy M. G. Taylor und Janis V. Giorgi. „Calculation and use of an HIV-1 disease progression score“. AIDS 14, Nr. 17 (Dezember 2000): 2715–22. http://dx.doi.org/10.1097/00002030-200012010-00011.
Der volle Inhalt der QuellePihlstrøm, Lasse, Kristina Rebekka Morset, Espen Grimstad, Valeria Vitelli und Mathias Toft. „A cumulative genetic risk score predicts progression in Parkinson's disease“. Movement Disorders 31, Nr. 4 (08.02.2016): 487–90. http://dx.doi.org/10.1002/mds.26505.
Der volle Inhalt der QuelleUngaro, R., R. Jordan, C. Yzet, P. Bossuyt, F. Baert, T. Vanasek, G. R. D’Haens et al. „P240 CDEIS score of 2 is optimal cut-off associated with lower risk of disease progression in early Crohn’s disease: Data from the CALM study“. Journal of Crohn's and Colitis 14, Supplement_1 (Januar 2020): S264—S266. http://dx.doi.org/10.1093/ecco-jcc/jjz203.369.
Der volle Inhalt der QuelleMoore, Ursula, Marni Jacobs, Meredith K. James, Anna G. Mayhew, Roberto Fernandez-Torron, Jia Feng, Avital Cnaan et al. „Assessment of disease progression in dysferlinopathy“. Neurology 92, Nr. 5 (09.01.2019): e461-e474. http://dx.doi.org/10.1212/wnl.0000000000006858.
Der volle Inhalt der QuelleShi, Manman, Yan Ouyang, Mingxin Yang, Meng Yang, Xiaoyan Zhang, Wei Huang, Weiming Wang et al. „IgA Nephropathy Susceptibility Loci and Disease Progression“. Clinical Journal of the American Society of Nephrology 13, Nr. 9 (24.07.2018): 1330–38. http://dx.doi.org/10.2215/cjn.13701217.
Der volle Inhalt der QuelleJönsson, Linus, Milana Ivkovic, Ron Handels, Anders Gustavsson, Teresa León, Julie Hviid Hahn-Pedersen und Lars Lau Raket. „OP142 Progression Analysis Versus Traditional Methods To Quantify Slowing Of Disease Progression In Alzheimer’s Disease“. International Journal of Technology Assessment in Health Care 39, S1 (Dezember 2023): S42. http://dx.doi.org/10.1017/s0266462323001435.
Der volle Inhalt der QuelleViticchi, Giovanna, Lorenzo Falsetti, Laura Buratti, Cristiano Boria, Simona Luzzi, Marco Bartolini, Leandro Provinciali und Mauro Silvestrini. „Framingham risk score can predict cognitive decline progression in Alzheimer's disease“. Neurobiology of Aging 36, Nr. 11 (November 2015): 2940–45. http://dx.doi.org/10.1016/j.neurobiolaging.2015.07.023.
Der volle Inhalt der QuelleRavindran, J., C. Cavill, C. Balakrishnan, S. M. Jones, E. Korendowych und N. J. McHugh. „A modified sharp score demonstrates disease progression in established psoriatic arthritis“. Arthritis Care & Research 62, Nr. 1 (15.01.2010): 86–91. http://dx.doi.org/10.1002/acr.20018.
Der volle Inhalt der QuelleKataoka, Hiroshi, und Kazuma Sugie. „Association between Fatigue and Hoehn-Yahr Staging in Parkinson’s Disease: Eight-Year Follow-Up Study“. Neurology International 13, Nr. 2 (26.05.2021): 224–31. http://dx.doi.org/10.3390/neurolint13020023.
Der volle Inhalt der QuellePreziosa, Paolo, Elisabetta Pagani, Alessandro Meani, Lucia Moiola, Mariaemma Rodegher, Massimo Filippi und Maria A. Rocca. „Slowly Expanding Lesions Predict 9-Year Multiple Sclerosis Disease Progression“. Neurology - Neuroimmunology Neuroinflammation 9, Nr. 2 (01.02.2022): e1139. http://dx.doi.org/10.1212/nxi.0000000000001139.
Der volle Inhalt der QuelleWang, Linbo, Wei Cheng, Edmund T. Rolls, Fuli Dai, Weikang Gong, Jingnan Du, Wei Zhang et al. „Association of specific biotypes in patients with Parkinson disease and disease progression“. Neurology 95, Nr. 11 (14.08.2020): e1445-e1460. http://dx.doi.org/10.1212/wnl.0000000000010498.
Der volle Inhalt der QuelleSwanson, Gregory P., Steven Stone, Lauren Lenz und Todd Cohen. „Ability of cell-cycle progression score to predict risk for progression to metastatic disease and disease-specific mortality in prostate cancer patients after prostatectomy.“ Journal of Clinical Oncology 38, Nr. 15_suppl (20.05.2020): 5524. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.5524.
Der volle Inhalt der QuelleKoc, G. H., M. R. Kok, J. Luime, I. Tchetverikov, F. R. Kasiem, K. Wervers, Y. Goekoop-Ruiterman et al. „OP0065 THE DETERMINANTS OF RADIOGRAPHIC PROGRESSION IN EARLY PSA PATIENTS“. Annals of the Rheumatic Diseases 82, Suppl 1 (30.05.2023): 44.2–45. http://dx.doi.org/10.1136/annrheumdis-2023-eular.5638.
Der volle Inhalt der QuelleMarkusse, Iris M., Linda Dirven, Marianne van den Broek, Casper Bijkerk, K. Huub Han, H. Karel Ronday, Rebecca Bolce et al. „A Multibiomarker Disease Activity Score for Rheumatoid Arthritis Predicts Radiographic Joint Damage in the BeSt Study“. Journal of Rheumatology 41, Nr. 11 (15.08.2014): 2114–19. http://dx.doi.org/10.3899/jrheum.131412.
Der volle Inhalt der QuelleLipshitz, Jay, Sewanti Limaye und Dilip Patel. „Leukocyte Alkaline Phosphatase Score as a Marker of Severity and Progression of Myelodysplastic Syndrome.“ Blood 110, Nr. 11 (16.11.2007): 4625. http://dx.doi.org/10.1182/blood.v110.11.4625.4625.
Der volle Inhalt der QuelleScelsi, Marzia A., Raiyan R. Khan, Marco Lorenzi, Leigh Christopher, Michael D. Greicius, Jonathan M. Schott, Sebastien Ourselin und Andre Altmann. „Genetic study of multimodal imaging Alzheimer’s disease progression score implicates novel loci“. Brain 141, Nr. 7 (30.05.2018): 2167–80. http://dx.doi.org/10.1093/brain/awy141.
Der volle Inhalt der QuelleEPSTEIN, JONATHAN I., CHARLES R. POUND, ALAN W. PARTIN und PATRICK C. WALSH. „DISEASE PROGRESSION FOLLOWING RADICAL PROSTATECTOMY IN MEN WITH GLEASON SCORE 7 TUMOR“. Journal of Urology 160, Nr. 1 (Juli 1998): 97–101. http://dx.doi.org/10.1016/s0022-5347(01)63045-3.
Der volle Inhalt der QuelleRossetti, Heidi C., C. Munro Cullum, Linda S. Hynan und Laura H. Lacritz. „The CERAD Neuropsychologic Battery Total Score and the Progression of Alzheimer Disease“. Alzheimer Disease & Associated Disorders 24, Nr. 2 (April 2010): 138–42. http://dx.doi.org/10.1097/wad.0b013e3181b76415.
Der volle Inhalt der QuelleMigliorelli, Carolina, Meritxell Gómez-Martinez, Paula Subías-Beltrán, Mireia Claramunt-Molet, Sebastian Idelsohn-Zielonka, Eudald Mas-Hurtado, Felip Miralles, Marisol Montolio, Marina Roselló-Ruano und Julita Medina-Cantillo. „Multidimensional Biomechanics-Based Score to Assess Disease Progression in Duchenne Muscular Dystrophy“. Sensors 23, Nr. 2 (11.01.2023): 831. http://dx.doi.org/10.3390/s23020831.
Der volle Inhalt der QuelleBergamaschi, Roberto, Silvana Quaglini, Eleonora Tavazzi, Maria Pia Amato, Damiano Paolicelli, Valentina Zipoli, Alfredo Romani et al. „Immunomodulatory therapies delay disease progression in multiple sclerosis“. Multiple Sclerosis Journal 22, Nr. 13 (20.07.2016): 1732–40. http://dx.doi.org/10.1177/1352458512445941.
Der volle Inhalt der QuelleHam, Young Rok, Eu Jin Lee, Hae Ri Kim, Jae Wan Jeon, Ki Ryang Na, Kang Wook Lee und Dae Eun Choi. „Ultrasound Renal Score to Predict the Renal Disease Prognosis in Patients with Diabetic Kidney Disease: An Investigative Study“. Diagnostics 13, Nr. 3 (31.01.2023): 515. http://dx.doi.org/10.3390/diagnostics13030515.
Der volle Inhalt der QuelleJehn, Lutz B., Ulrich Costabel, Eda Boerner, Julia Wälscher, Dirk Theegarten, Christian Taube und Francesco Bonella. „Serum KL-6 as a Biomarker of Progression at Any Time in Fibrotic Interstitial Lung Disease“. Journal of Clinical Medicine 12, Nr. 3 (01.02.2023): 1173. http://dx.doi.org/10.3390/jcm12031173.
Der volle Inhalt der QuelleKang, Min Kyoung, Jung Hwan Shin, Tae Jung Kim, Ji Sung Lee, Byung-Woo Yoon und Sang-Bae Ko. „Use of proton pump inhibitor may be associated with progression of cerebral small vessel disease“. PLOS ONE 17, Nr. 12 (21.12.2022): e0279257. http://dx.doi.org/10.1371/journal.pone.0279257.
Der volle Inhalt der QuellePavicic, Mirko, Kirk Overmyer, Attiq ur Rehman, Piet Jones, Daniel Jacobson und Kristiina Himanen. „Image-Based Methods to Score Fungal Pathogen Symptom Progression and Severity in Excised Arabidopsis Leaves“. Plants 10, Nr. 1 (15.01.2021): 158. http://dx.doi.org/10.3390/plants10010158.
Der volle Inhalt der QuelleChenniappan, Raghavi, Hanumanthappa Nandeesha, Shivanand Kattimani und Nandakumar Dalavaikodihalli Nanjaiah. „Interleukin-17 and Interleukin-10 Association with Disease Progression in Schizophrenia“. Annals of Neurosciences 27, Nr. 1 (Januar 2020): 24–28. http://dx.doi.org/10.1177/0972753120929565.
Der volle Inhalt der QuelleSegala, Francesco Vladimiro, Emanuele Rando, Federica Salvati, Marcantonio Negri, Francesca Catania, Flavia Sanmartin, Rita Murri, Evangelos J. Giamarellos-Bourboulis und Massimo Fantoni. „Anakinra in hospitalized COVID-19 patients guided by baseline soluble urokinase plasminogen receptor plasma levels: A real world, retrospective cohort study“. PLOS ONE 18, Nr. 4 (04.04.2023): e0273202. http://dx.doi.org/10.1371/journal.pone.0273202.
Der volle Inhalt der QuelleUmemoto, George, Shinsuke Fujioka, Yasuyuki Iwasa, Yoshie Ozaki, Kayoko Koga, Kazumi Nishimura und Yoshio Tsuboi. „Impact of Progression of Parkinson’s Disease on Swallowing Ability and Oral Environment“. Parkinson's Disease 2021 (23.04.2021): 1–6. http://dx.doi.org/10.1155/2021/5571556.
Der volle Inhalt der QuelleXie, Linjun, Keke Hou, Huayan Xu, Hang Fu, Rong Xu, Hui Liu, Zhongqin Zhou, Zhenlin Li, Ming Yang und Yingkun Guo. „Chest CT features and progression of patients with coronavirus disease 2019“. British Journal of Radiology 93, Nr. 1116 (01.12.2020): 20200219. http://dx.doi.org/10.1259/bjr.20200219.
Der volle Inhalt der QuelleTsai, Tsung-Ying, Pai-Feng Hsu, Cheng-Hsueh Wu, Shao-Sung Huang, Wan-Leong Chan, Shing-Jong Lin, Jaw-Wen Chen, Tse-Min Lu und Hsin-Bang Leu. „Association between Coronary Artery Plaque Progression and Liver Fibrosis Biomarkers in Population with Low Calcium Scores“. Nutrients 14, Nr. 15 (30.07.2022): 3163. http://dx.doi.org/10.3390/nu14153163.
Der volle Inhalt der QuelleChen, Szu-Ju, Yu-Chiao Chi, Chang-Han Ho, Wei-Shiung Yang und Chin-Hsien Lin. „Plasma Lipopolysaccharide-Binding Protein Reflects Risk and Progression of Parkinson’s Disease“. Journal of Parkinson's Disease 11, Nr. 3 (02.08.2021): 1129–39. http://dx.doi.org/10.3233/jpd-212574.
Der volle Inhalt der QuelleJedynak, Bruno M., Andrew Lang, Bo Liu, Elyse Katz, Yanwei Zhang, Bradley T. Wyman, David Raunig, C. Pierre Jedynak, Brian Caffo und Jerry L. Prince. „A computational neurodegenerative disease progression score: Method and results with the Alzheimer's disease neuroimaging initiative cohort“. NeuroImage 63, Nr. 3 (November 2012): 1478–86. http://dx.doi.org/10.1016/j.neuroimage.2012.07.059.
Der volle Inhalt der QuelleYavuz, Yasemin. „Are the Beck depression inventory score, SF 36 score and progression of the disease changing with education in chronic kidney disease patients?“ Annals of Medical Research 25, Nr. 4 (2018): 723. http://dx.doi.org/10.5455/annalsmedres.2018.05.091.
Der volle Inhalt der QuelleYang, Yongbo, Jian Wang, Qun Liang, Yi Wang, Xinhua Chen, Qingrong Zhang, Shijie Na et al. „PHACTR1 is associated with disease progression in Chinese Moyamoya disease“. PeerJ 8 (05.05.2020): e8841. http://dx.doi.org/10.7717/peerj.8841.
Der volle Inhalt der QuelleOefelein, Michael G. „RE: DISEASE PROGRESSION FOLLOWING RADICAL PROSTATECTOMY IN MEN WITH GLEASON SCORE 7 TUMOR“. Journal of Urology 161, Nr. 1 (Januar 1999): 231. http://dx.doi.org/10.1016/s0022-5347(01)62114-1.
Der volle Inhalt der QuelleSerednicka, K., A. E. Smyth, C. M. Black und C. P. Denton. „Using a self-reported functional score to assess disease progression in systemic sclerosis“. Rheumatology 46, Nr. 7 (09.05.2007): 1107–10. http://dx.doi.org/10.1093/rheumatology/kel432.
Der volle Inhalt der QuelleHarrison, Madaline B., Scott A. Wylie, Robert C. Frysinger, James T. Patrie, Diane S. Huss, Lillian J. Currie und G. Frederick Wooten. „UPDRS activity of daily living score as a marker of Parkinson's disease progression“. Movement Disorders 24, Nr. 2 (30.01.2009): 224–30. http://dx.doi.org/10.1002/mds.22335.
Der volle Inhalt der QuelleRodríguez-Rodríguez, E., P. Sánchez-Juan, J. L. Vázquez-Higuera, I. Mateo, A. Pozueta, J. Berciano, S. Cervantes et al. „Genetic risk score predicting accelerated progression from mild cognitive impairment to Alzheimer’s disease“. Journal of Neural Transmission 120, Nr. 5 (20.11.2012): 807–12. http://dx.doi.org/10.1007/s00702-012-0920-x.
Der volle Inhalt der QuelleGao, Yang, Hong-Liang Zhang, Meiying Xin, Dong Wang, Nannan Zheng, Shuang Wang, Jiancheng Xu, Ying Wang, Jie Zhu und Jiachun Feng. „Serum Folate Correlates with Severity of Guillain-Barré Syndrome and Predicts Disease Progression“. BioMed Research International 2018 (14.06.2018): 1–5. http://dx.doi.org/10.1155/2018/5703279.
Der volle Inhalt der QuelleRossi, Silvia, Fabio Buttari, Valeria Studer, Caterina Motta, Paolo Gravina, Maura Castelli, Vilma Mantovani et al. „The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis“. Multiple Sclerosis Journal 17, Nr. 3 (08.12.2010): 281–88. http://dx.doi.org/10.1177/1352458510388680.
Der volle Inhalt der QuelleHasimoglu, Yasemin G., Xiqun Chen, Rachit Bakshi, Michael A. Schwarzschild und Eric A. Macklin. „Does Serum Urate Change as Parkinson’s Disease Progresses?“ Journal of Parkinson's Disease 10, Nr. 4 (27.10.2020): 1571–76. http://dx.doi.org/10.3233/jpd-202064.
Der volle Inhalt der QuelleStopsack, Konrad H., Charles A. Whittaker, Travis A. Gerke, Massimo Loda, Philip W. Kantoff, Lorelei A. Mucci und Angelika Amon. „Aneuploidy drives lethal progression in prostate cancer“. Proceedings of the National Academy of Sciences 116, Nr. 23 (13.05.2019): 11390–95. http://dx.doi.org/10.1073/pnas.1902645116.
Der volle Inhalt der QuelleSharad, Shashwat, Zsã³fia Sztupinszki, Zoltan Szallasi, Inger L. Rosner, Shiv Srivastava, Albert Dobi, Jennifer Cullen und Hua Li. „PMEPA1 gene isoforms to indicate disease progression in solid tumors.“ Journal of Clinical Oncology 37, Nr. 15_suppl (20.05.2019): e16580-e16580. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e16580.
Der volle Inhalt der QuelleKister, Ilya, und Orhun H. Kantarci. „Multiple Sclerosis Severity Score: Concept and applications“. Multiple Sclerosis Journal 26, Nr. 5 (22.01.2020): 548–53. http://dx.doi.org/10.1177/1352458519880125.
Der volle Inhalt der QuelleGautam, Sachin, Rahul Kumar, Dharam Pal Bhadoria, Govind Mawari, Naresh Kumar, Mradul K. Daga, Sanjay Pandit et al. „Clinical profile of hospitalised moderate category COVID-19 patients: Short study from a Tertiary Care Centre in Delhi“. Journal of Family Medicine and Primary Care 12, Nr. 8 (August 2023): 1644–53. http://dx.doi.org/10.4103/jfmpc.jfmpc_2245_22.
Der volle Inhalt der QuelleMills, James A., Jeffrey D. Long, Amrita Mohan, Jennifer J. Ware und Cristina Sampaio. „Cognitive and Motor Norms for Huntington’s Disease“. Archives of Clinical Neuropsychology 35, Nr. 6 (14.05.2020): 671–82. http://dx.doi.org/10.1093/arclin/acaa026.
Der volle Inhalt der QuelleBrandt, L., H. Schulze-Koops, T. Hügle, M. J. Nissen, H. Paul und R. Muller. „OP0185 RADIOGRAPHIC PROGRESSION DESPITE PERSISTENT LDA OR REMISSION IS INFLUENCED BY CURRENT SMOKING RATHER THAN THE RESPECTIVE DAS 28 LEVEL, RESULTS OF THE SWISS RHEUMATOID ARTHRITIS REGISTER (SCQM)“. Annals of the Rheumatic Diseases 80, Suppl 1 (19.05.2021): 112.1–112. http://dx.doi.org/10.1136/annrheumdis-2021-eular.2557.
Der volle Inhalt der QuelleClancy, Una, Stephen D. J. Makin, Caroline A. McHutchison, Vera Cvoro, Francesca M. Chappell, Maria del C. Valdés Hernández, Eleni Sakka, Fergus Doubal und Joanna M. Wardlaw. „Impact of Small Vessel Disease Progression on Long-term Cognitive and Functional Changes After Stroke“. Neurology 98, Nr. 14 (07.02.2022): e1459-e1469. http://dx.doi.org/10.1212/wnl.0000000000200005.
Der volle Inhalt der QuelleMello, Ricardo Andrade Fernandes de, Melissa Bosi Nonato Mello, Laís Bastos Pessanha und Ana Paula Alves Fonseca. „Skeletal involvement in Gaucher disease: extent of bone disease, splenic volume, and quality of life“. Radiologia Brasileira 54, Nr. 2 (April 2021): 71–76. http://dx.doi.org/10.1590/0100-3984.2020.0014.
Der volle Inhalt der QuelleJedynak, Bruno, Zhou Ye, Andrew Lang, Runze Tang, Pierre Jedynak und Jerry Prince. „P1-197: The Alzheimer's Disease Progression Score (ADPS) can predict the transition from MCI to Alzheimer's disease“. Alzheimer's & Dementia 9 (Juli 2013): P223. http://dx.doi.org/10.1016/j.jalz.2013.05.420.
Der volle Inhalt der Quelle